Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $31.8500 (-2.9%) ($31.8500 - $31.8500) on Tue. Oct. 19, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.58% (three month average) | RSI | 40 | Latest Price | $31.8500(-2.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.4% a day on average for past five trading days. | Weekly Trend | TGTX advances 0.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(69%) ARKG(65%) ARKK(61%) IBB(61%) IWO(60%) | Factors Impacting TGTX price | TGTX will decline at least -2.29% in a week (0% probabilities). VIXM(-48%) VXX(-39%) UUP(-19%) UNG(-6%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.29% (StdDev 4.58%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $32.54 | 5 Day Moving Average | $32.92(-3.25%) | 10 Day Moving Average | $32.35(-1.55%) | 20 Day Moving Average | $32.54(-2.12%) | To recent high | -16.3% | To recent low | 46.9% | Market Cap | $4.034b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |